Source:http://linkedlifedata.com/resource/pubmed/id/10828089
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-8-2
|
pubmed:abstractText |
We investigated the lipoprotein distribution and composition in cerebrospinal fluid (CSF) in a group of patients with Alzheimer's disease (AD) or affected by other types of dementia in comparison to non-demented controls. We found slightly decreased apolipoprotein (apo)E and cholesterol concentrations in CSF of AD patients and moderately increased apoA-I concentrations, while in patients suffering from other types of dementia the apoA-I CSF concentration was increased. ApoA-IV concentrations varied widely in human CSF, but were not associated with any clinical condition. HDL(2)-like apoE-containing lipoproteins represent the major lipoprotein fraction. In CSF of normal controls, only a minor HDL(3)-like apoA-I-containing lipoprotein fraction was observed; this fraction was more prevalent in AD patients. ApoA-II was recovered mostly in the HDL(3) density range, while apoA-IV was not associated with lipoproteins but appeared in a lipid-free form, co-localizing with LCAT immunoreactivity. Bi-dimensional analysis demonstrated pre-beta and alpha apoA-I-containing particles; apoE and apoA-II were detected only in alpha-migrating particles. ApoA-IV distributed both to pre-beta and gamma-migrating particles; the LCAT signal was co-localized in this gamma-migrating fraction. Enzymatically active LCAT was present in human CSF as well as PLTP activity and mass; no CETP mass was detected. In CSF from AD patients, LCAT activity was 50% lower than in CSF from normal controls. CSF lipoproteins induced a significant cholesterol efflux from cultured rat astrocytes, suggesting that they play an active role in maintaining the cholesterol homeostasis in brain cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylcholine-Sterol...,
http://linkedlifedata.com/resource/pubmed/chemical/lipid transfer protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-2275
|
pubmed:author |
pubmed-author:CastroGG,
pubmed-author:De DeynP PPP,
pubmed-author:De GeitereCC,
pubmed-author:DemeesterNN,
pubmed-author:DesrumauxCC,
pubmed-author:EngelborghsSS,
pubmed-author:FruchartJ CJC,
pubmed-author:LabeurCC,
pubmed-author:MullenersEE,
pubmed-author:RosseneuMM,
pubmed-author:SantensPP,
pubmed-author:VandekerckhoveJJ
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
963-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10828089-Alzheimer Disease,
pubmed-meshheading:10828089-Animals,
pubmed-meshheading:10828089-Biological Transport,
pubmed-meshheading:10828089-Blotting, Western,
pubmed-meshheading:10828089-Carrier Proteins,
pubmed-meshheading:10828089-Case-Control Studies,
pubmed-meshheading:10828089-Cells, Cultured,
pubmed-meshheading:10828089-Cholesterol,
pubmed-meshheading:10828089-Humans,
pubmed-meshheading:10828089-Lipoproteins,
pubmed-meshheading:10828089-Phosphatidylcholine-Sterol O-Acyltransferase,
pubmed-meshheading:10828089-Rats,
pubmed-meshheading:10828089-Ultracentrifugation
|
pubmed:year |
2000
|
pubmed:articleTitle |
Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease.
|
pubmed:affiliation |
Department of Biochemistry, University of Gent, B-9000 Gent, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|